Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.140
-0.310 (-8.99%)
At close: Nov 20, 2026, 4:00 PM EST
3.100
-0.040 (-1.27%)
After-hours: Nov 20, 2026, 7:49 PM EST
Inventiva Market Cap
Inventiva has a market cap or net worth of $761.4 million as of November 20, 2026. Its market cap has decreased by 0.15% in one year.
Market Cap
761.40M
Enterprise Value
731.38M
1-Year Change
-0.15%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 10, 2020, Inventiva's market cap has increased from $547.96M to $761.40M, an increase of 38.95%. That is a compound annual growth rate of 5.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 761.40M | -13.95% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Odyssey Therapeutics | 879.24M |
| Latigo Biotherapeutics | 877.80M |
| Verastem | 864.46M |
| Pharming Group | 844.83M |
| Corvus Pharmaceuticals | 844.37M |
| Syndax Pharmaceuticals | 821.96M |
| Mentari Therapeutics | 805.15M |
| ORIC Pharmaceuticals | 800.27M |